期刊
ANNALS OF TRANSLATIONAL MEDICINE
卷 3, 期 22, 页码 -出版社
AME PUBL CO
DOI: 10.3978/j.issn.2305-5839.2015.11.22
关键词
YKL-40; non-muscle invasive bladder cancer (NMIBC); recurrence; serum
资金
- Natural Science Foundation of Shanghai [14ZR1432300]
Background: To explore the clinical correlation between serum YKL-40 protein level and recurrence of nonmuscle invasive bladder cancer (NMIBC). Methods: Totally 76 NMIBC patients (including 34 patients with confirmed recurrence and 42 patients without recurrence during the 2-year post-operative follow-up) and 31 healthy volunteers were recruited in this study. Blood samples were collected early in the morning, and serum YKL-40 protein levels of all these patients were analysed by using enzyme-linked immunosorbent assay (ELISA). Results: Serum YKL-40 protein levels were significantly higher in NMIBC patients than in healthy controls (P<0.001). Meanwhile, serum YKL-40 protein levels were found to be significantly higher in patients with recurrent NMIBC than those without tumor recurrence (P=0.001). Conclusions: Serum YKL-40 protein can be a reliable molecular marker for the clinical diagnosis of NMIBC recurrence. In particular, it can inform the post-operative management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据